1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Check out our weekly earnings calendar and read the latest quarterly earnings previews.
Most of the buy-and-hold crowd tends to steer clear of biotech stocks, and for good reason. Biotechnology companies can be uncomfortably risky. Far too many horror stories of failed drug trials or the...
The Dividend Aristocrats are an elite group of 53 stocks that have at least one thing in common: They have raised their annual payout in at least each of the past 25 years, if not longer.
More Investing News »